Cutaneous HPV and skin cancer

Presse Medicale

Volumn 43, Issue 12, 2014, Pages e435-e443

  Accardi, Rosita ^a   Gheit, Tarik ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS DNA;

ACTINIC KERATOSIS; CANCER PATIENT; CANCER RISK; DEVELOPMENTAL STAGE; EPIDERMODYSPLASIA VERRUCIFORMIS; GENETIC ORGANIZATION; GENOMICS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 7; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED PATIENT; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PAPILLOMAVIRUS INFECTION; PREVALENCE; RADIATION EXPOSURE; SHORT SURVEY; SKIN CANCER; SKIN CARCINOGENESIS; SKIN CARCINOMA; SUN EXPOSURE; ULTRAVIOLET RADIATION; VIRAL SKIN DISEASE; VIRUS ISOLATION; VIRUS LOAD; VIRUS STRAIN; VIRUS TRANSFORMATION; VIRUS TYPING; WART VIRUS; COMPLICATION; PAPILLOMAVIRIDAE; PATHOGENICITY; PHYSIOLOGY; SKIN TUMOR; VIROLOGY; VIRUS CELL TRANSFORMATION;

CELL TRANSFORMATION, VIRAL; EPIDERMODYSPLASIA VERRUCIFORMIS; HUMANS; IMMUNOCOMPROMISED HOST; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SKIN DISEASES, VIRAL; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 84923082151     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2014.08.008     Document Type: Short Survey

References (93)

1. de Villiers E.M. Cross-roads in the classification of papillomaviruses. Virology 2013, 445:2-10.
2. Bottalico D., Chen Z., Dunne A., et al. The oral cavity contains abundant known and novel human papillomaviruses from the Betapapillomavirus and Gammapapillomavirus genera. J Infect Dis 2011, 204:787-792.
3. Bottalico D., Chen Z., Kocjan B.J., et al. Characterization of human papillomavirus type 120: a novel betapapillomavirus with tropism for multiple anatomical niches. J Gen Virol 2012, 93:1774-1779.
4. Martin E., Dang J., Bzhalava D., et al. Characterization of three novel human papillomavirus types isolated from oral rinse samples of healthy individuals. J Clin Virol 2014, 59:30-37.
5. Bernard H.U., Burk R.D., Chen Z., et al. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010, 401:70-79.
6. de Villiers E.M., Fauquet C., Broker T.R., et al. Classification of papillomaviruses. Virology 2004, 324:17-27.
7. Bouvard V., Baan R., Straif K., Grosse Y., et al. A review of human carcinogens-part B: biological agents. Lancet Oncol 2009, 10:321-322.
8. Anantharaman D., Gheit T., Waterboer T., et al. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study. J Natl Cancer Inst 2013, 105:536-545.
9. McLaughlin-Drubin M.E., Meyers J., Munger K. Cancer associated human papillomaviruses. Curr Opin Virol 2012, 2:459-466.
10. Pfister H. Chapter 8: human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 2003, 31:52-56.
11. Favre M., Ramoz N., Orth G. Human papillomaviruses: general features. Clin Dermatol 1997, 15:181-198.
12. Halbert C.L., Galloway D.A. Identification of the E5 open reading frame of human papillomavirus type 16. J Virol 1988, 62:1071-1075.
13. Leechanachai P., Banks L., Moreau F., et al. The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus. Oncogene 1992, 7:19-25.
14. Chen Z., Schiffman M., Herrero R., et al. Human papillomavirus (HPV) types 101 and 103 isolated from cervicovaginal cells lack an E6 open reading frame (ORF) and are related to gamma-papillomaviruses. Virology 2007, 360:447-453.
15. Nobre R.J., Herraez-Hernandez E., Fei J.W., et al. E7 oncoprotein of novel human papillomavirus type 108 lacking the E6 gene induces dysplasia in organotypic keratinocyte cultures. J Virol 2009, 83:2907-2916.
16. Egawa K. Do human papillomaviruses target epidermal stem cells?. Dermatology 2003, 207:251-254.
17. Neale R.E., Weissenborn S., Abeni D., et al. Human papillomavirus load in eyebrow hair follicles and risk of cutaneous squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2013, 22:719-727.
18. Schmitt A., Rochat A., Zeltner R., et al. The primary target cells of the high-risk cottontail rabbit papillomavirus colocalize with hair follicle stem cells. J Virol 1996, 70:1912-1922.
19. de Koning M.N., Weissenborn S.J., Abeni D., et al. Prevalence and associated factors of betapapillomavirus infections in individuals without cutaneous squamous cell carcinoma. J Gen Virol 2009, 90:1611-1621.
20. Antonsson A., Karanfilovska S., Lindqvist P.G., et al. General acquisition of human papillomavirus infections of skin occurs in early infancy. J Clin Microbiol 2003, 41:2509-2514.
21. Weissenborn S.J., De Koning M.N., Wieland U., et al. Intrafamilial transmission and family-specific spectra of cutaneous betapapillomaviruses. J Virol 2009, 83:811-816.
22. Plasmeijer E.I., Neale R.E., O'Rourke P., et al. Lack of association between the presence and persistence of betapapillomavirus DNA in eyebrow hairs and betapapillomavirus L1 antibodies in serum. J Gen Virol 2010, 91:2073-2079.
23. Dillner J. The serological response to papillomaviruses. Semin Cancer Biol 1999, 9:423-430.
24. Stanley M.A. Immune responses to human papilloma viruses. Indian J Med Res 2009, 130:266-276.
25. Michael K.M., Waterboer T., Sehr P., et al. Seroprevalence of 34 human papillomavirus types in the German general population. PLoS Pathog 2008, 4:e1000091.
26. Iannacone M.R., Michael K.M., Giuliano A.R., et al. Risk factors for cutaneous human papillomavirus seroreactivity among patients undergoing skin cancer screening in Florida. J Infect Dis 2010, 201:760-769.
27. Kohler A., Forschner T., Meyer T., et al. Multifocal distribution of cutaneous human papillomavirus types in hairs from different skin areas. Br J Dermatol 2007, 156:1078-1080.
28. Orth G. Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Semin Immunol 2006, 18:362-374.
29. Lomas A., Leonardi-Bee J., Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012, 166:1069-1080.
30. Forslund O., Iftner T., Andersson K., et al. Cutaneous human papillomaviruses found in sun-exposed skin: Beta-papillomavirus species 2 predominates in squamous cell carcinoma. J Infect Dis 2007, 196:876-883.
31. Purdie K.J., Pennington J., Proby C.M., et al. The promoter of a novel human papillomavirus (HPV77) associated with skin cancer displays UV responsiveness, which is mediated through a consensus p53 binding sequence. EMBO J 1999, 18:5359-5369.
32. Akgul B., Lemme W., Garcia-Escudero R., et al. UV-B irradiation stimulates the promoter activity of the high-risk, cutaneous human papillomavirus 5 and 8 in primary keratinocytes. Arch Virol 2005, 150:145-151.
33. Kripke M.L. Ultraviolet radiation and immunology: something new under the sun-presidential address. Cancer Res 1994, 54:6102-6105.
34. Jablonska S., Dabrowski J., Jakubowicz K. Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res 1972, 32:583-589.
35. Patel A.S., Karagas M.R., Pawlita M., et al. Cutaneous human papillomavirus infection, the EVER2 gene and incidence of squamous cell carcinoma: a case-control study. Int J Cancer 2008, 122:2377-2379.
36. Lazarczyk M., Cassonnet P., Pons C., et al. The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections. Microbiol Mol Biol Rev 2009, 73:348-370.
37. Dell'Oste V., Azzimonti B., De Andrea M., et al. High beta-HPV DNA loads and strong seroreactivity are present in epidermodysplasia verruciformis. J Invest Dermatol 2009, 129:1026-1034.
38. Borgogna C., Zavattaro E., De Andrea M., et al. Characterization of beta papillomavirus E4 expression in tumours from Epidermodysplasia Verruciformis patients and in experimental models. Virology 2012, 423:195-204.
39. Borgogna C., Lanfredini S., Peretti A., et al. Improved detection reveals active beta-papillomavirus infection in skin lesions from kidney transplant recipients. Mod Pathol 2014, 27:1101-1115.
40. Lindelof B., Sigurgeirsson B., Gabel H., et al. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000, 143:513-519.
41. Nindl I., Gottschling M., Stockfleth E. Human papillomaviruses and non-melanoma skin cancer: basic virology and clinical manifestations. Dis Markers 2007, 23:247-259.
42. Proby C.M., Harwood C.A., Neale R.E., et al. A case-control study of betapapillomavirus infection and cutaneous squamous cell carcinoma in organ transplant recipients. Am J Transplant 2011, 11:1498-1508.
43. Silverberg M.J., Leyden W., Warton E.M., et al. HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer. J Natl Cancer Inst 2013, 105:350-360.
44. Grulich A.E., van Leeuwen M.T., Falster M.O., et al. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007, 370:59-67.
45. Patel A.S., Karagas M.R., Perry A.E., et al. Exposure profiles and human papillomavirus infection in skin cancer: an analysis of 25 genus beta-types in a population-based study. J Invest Dermatol 2008, 128:2888-2893.
46. Iannacone M.R., Gheit T., Pfister H., et al. Case-control study of genus-beta human papillomaviruses in plucked eyebrow hairs and cutaneous squamous cell carcinoma. Int J Cancer 2014, 134:2231-2244.
47. Mackintosh L.J., de Koning M.N., Quint W.G., et al. Presence of beta human papillomaviruses in nonmelanoma skin cancer from organ transplant recipients and immunocompetent patients in the West of Scotland. Br J Dermatol 2009, 161:56-62.
48. Iannacone M.R., Gheit T., Waterboer T., et al. Case-control study of cutaneous human papillomavirus infection in basal cell carcinoma of the skin. J Invest Dermatol 2013, 133:1512-1520.
49. Struijk L., Bouwes Bavinck J.N., Wanningen P., et al. Presence of human papillomavirus DNA in plucked eyebrow hairs is associated with a history of cutaneous squamous cell carcinoma. J Invest Dermatol 2003, 121:1531-1535.
50. Karagas M.R., Nelson H.H., Sehr P., et al. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 2006, 98:389-395.
51. Waterboer T., Abeni D., Sampogna F., et al. Serological association of beta and gamma human papillomaviruses with squamous cell carcinoma of the skin. Br J Dermatol 2008, 159:457-459.
52. Farzan S.F., Waterboer T., Gui J., et al. Cutaneous alpha, beta and gamma human papillomaviruses in relation to squamous cell carcinoma of the skin: a population-based study. Int J Cancer 2013, 133:1713-1720.
53. Iannacone M.R., Gheit T., Waterboer T., et al. Case-control study of cutaneous human papillomaviruses in squamous cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev 2012, 21:1303-1313.
54. Karagas M.R., Waterboer T., Li Z., et al. Genus beta human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: population based case-control study. BMJ 2010, 341:c2986.
55. Struijk L., Hall L., van der Meijden E., et al. Markers of cutaneous human papillomavirus infection in individuals with tumor-free skin, actinic keratoses, and squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2006, 15:529-535.
56. Gheit T., Billoud G., de Koning M.N., et al. Development of a sensitive and specific multiplex PCR method combined with DNA microarray primer extension to detect Betapapillomavirus types. J Clin Microbiol 2007, 45:2537-2544.
57. de Koning M., Quint W., Struijk L., et al. Evaluation of a novel highly sensitive, broad-spectrum PCR-reverse hybridization assay for detection and identification of beta-papillomavirus DNA. J Clin Microbiol 2006, 44:1792-1800.
58. Weissenborn S.J., Nindl I., Purdie K., et al. Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. J Invest Dermatol 2005, 125:93-97.
59. zur Hausen H. Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta 1996, 1288:F55-F78.
60. Arron S.T., Ruby J.G., Dybbro E., et al. Transcriptome sequencing demonstrates that human papillomavirus is not active in cutaneous squamous cell carcinoma. J Invest Dermatol 2011, 131:1745-1753.
61. Moody C.A., Laimins L.A. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 2010, 10:550-560.
62. Howie H.L., Katzenellenbogen R.A., Galloway D.A. Papillomavirus E6 proteins. Virology 2009, 384:324-334.
63. Banks L., Pim D., Thomas M. Human tumour viruses and the deregulation of cell polarity in cancer. Nat Rev Cancer 2012, 12:877-886.
64. Cornet I., Bouvard V., Campo M.S., et al. Comparative analysis of transforming properties of E6 and E7 from different beta human papillomavirus types. J Virol 2012, 86:2366-2370.
65. Schmitt A., Harry J.B., Rapp B., et al. Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1. J Virol 1994, 68:7051-7059.
66. Viarisio D., Mueller-Decker K., Kloz U., et al. E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice. PLoS Pathog 2011, 7:e1002125.
67. Dong W., Kloz U., Accardi R., et al. Skin hyperproliferation and susceptibility to chemical carcinogenesis in transgenic mice expressing E6 and E7 of human papillomavirus type 38. J Virol 2005, 79:14899-14908.
68. Schaper I.D., Marcuzzi G.P., Weissenborn S.J., et al. Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. Cancer Res 2005, 65:1394-1400.
69. Holloway A., Storey A. A conserved C-terminal sequence of high-risk cutaneous beta-human papillomavirus E6 proteins alters localization and signalling of beta1-integrin to promote cell migration. J Gen Virol 2014, 95:123-134.
70. Rozenblatt-Rosen O., Deo R.C., Padi M., et al. Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. Nature 2012, 487:491-495.
71. Patel D., Huang S.M., Baglia L.A., et al. The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO J 1999, 18:5061-5072.
72. Zimmermann H., Degenkolbe R., Bernard H.U., et al. The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300. J Virol 1999, 73:6209-6219.
73. Muench P., Probst S., Schuetz J., et al. Cutaneous papillomavirus E6 proteins must interact with p300 and block p53-mediated apoptosis for cellular immortalization and tumorigenesis. Cancer Res 2010, 70:6913-6924.
74. Howie H.L., Koop J.I., Weese J., et al. Beta-HPV 5 and 8 E6 promote p300 degradation by blocking AKT/p300 association. PLoS Pathog 2011, 7:e1002211.
75. Wallace N.A., Robinson K., Howie H.L., et al. HPV 5 and 8 E6 abrogate ATR activity resulting in increased persistence of UVB induced DNA damage. PLoS Pathog 2012, 8:e1002807.
76. Wallace N.A., Galloway D.A. Manipulation of cellular DNA damage repair machinery facilitates propagation of human papillomaviruses. Semin Cancer Biol 2014, 26:30-42.
77. Muschik D., Braspenning-Wesch I., Stockfleth E., et al. Cutaneous HPV23 E6 prevents p53 phosphorylation through interaction with HIPK2. PLoS One 2011, 6:e27655.
78. Wallace N.A., Robinson K., Galloway D.A. Beta human papillomavirus E6 expression inhibits stabilization of p53 and increases tolerance of genomic instability. J Virol 2014, 88:6112-6127.
79. Simmonds M., Storey A. Identification of the regions of the HPV 5 E6 protein involved in Bak degradation and inhibition of apoptosis. Int J Cancer 2008, 123:2260-2266.
80. Shay J.W., Wright W.E. Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 2005, 26:867-874.
81. Gabet A.S., Accardi R., Bellopede A., et al. Impairment of the telomere/telomerase system and genomic instability are associated with keratinocyte immortalization induced by the skin human papillomavirus type 38. FASEB J 2008, 22:622-632.
82. Bedard K.M., Underbrink M.P., Howie H.L., et al. The E6 oncoproteins from human betapapillomaviruses differentially activate telomerase through an E6AP-dependent mechanism and prolong the lifespan of primary keratinocytes. J Virol 2008, 82:3894-3902.
83. Brimer N., Lyons C., Wallberg A.E., et al. Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling. Oncogene 2012, 31:4639-4646.
84. Rangarajan A., Talora C., Okuyama R., et al. Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J 2001, 20:3427-3436.
85. Proweller A., Tu L., Lepore J.J., et al. Impaired notch signaling promotes de novo squamous cell carcinoma formation. Cancer Res 2006, 66:7438-7444.
86. Giarre M., Caldeira S., Malanchi I., et al. Induction of pRb degradation by the human papillomavirus type 16 E7 protein is essential to efficiently overcome p16INK4a-imposed G1 cell cycle arrest. J Virol 2001, 75:4705-4712.
87. Cobrinik D. Pocket proteins and cell cycle control. Oncogene 2005, 24:2796-2809.
88. Akgul B., Ghali L., Davies D., et al. HPV8 early genes modulate differentiation and cell cycle of primary human adult keratinocytes. Exp Dermatol 2007, 16:590-599.
89. Accardi R., Dong W., Smet A., et al. Skin human papillomavirus type 38 alters p53 functions by accumulation of deltaNp73. EMBO Rep 2006, 7:334-340.
90. Accardi R., Scalise M., Gheit T., et al. IkappaB kinase beta promotes cell survival by antagonizing p53 functions through DeltaNp73alpha phosphorylation and stabilization. Mol Cell Biol 2011, 31:2210-2226.
91. Saidj D., Cros M.P., Hernandez-Vargas H., et al. Oncoprotein E7 from beta human papillomavirus 38 induces formation of an inhibitory complex for a subset of p53-regulated promoters. J Virol 2013, 87:12139-12150.
92. Hufbauer M., Biddle A., Borgogna C., et al. Expression of betapapillomavirus oncogenes increases the number of keratinocytes with stem cell-like properties. J Virol 2013, 87:12158-12165.
93. Paschos K., Allday M.J. Epigenetic reprogramming of host genes in viral and microbial pathogenesis. Trends Microbiol 2010, 18:439-447.